• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

北阿坎德邦一家三级护理医院医护人员中抗新冠病毒 2 型抗体的血清流行率:一项回顾性研究

Seroprevalence of Antibodies Against SARS-CoV-2 Among Health Care Workers at a Tertiary Care Hospital in Uttarakhand: A Retrospective Study.

作者信息

Saini Amit K, Panda Prasan K, Bahurupi Yogesh, Omar Balram, T Akhil, Panwar Pooja, Sharma Maneesh

机构信息

Department of Nursing, All India Institute of Medical Sciences, Rishikesh, Rishikesh, IND.

Department of Internal Medicine, All India Institute of Medical Sciences, Rishikesh, Rishikesh, IND.

出版信息

Cureus. 2022 May 9;14(5):e24840. doi: 10.7759/cureus.24840. eCollection 2022 May.

DOI:10.7759/cureus.24840
PMID:35693358
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9175072/
Abstract

Background The number of confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections is vastly underestimated. In this context, seroprevalence surveys are of utmost importance to assess the proportion of the population that has already developed antibodies against the virus and might potentially be protected against subsequent infection. Health care workers (HCWs) face a greater risk of developing SARS-CoV-2. Therefore, the present retrospective study was undertaken to estimate the prevalence of antibodies against SARS-CoV-2 among healthcare workers at a tertiary care institute in Uttarakhand, India. Material and methods Data were gathered from hospital records of 704 healthcare workers admitted to the coronavirus disease 2019 (COVID-19) unit and attended the COVID OPD of the tertiary care institute between July 15 to Aug 14, 2020. Result Out of the 704 recruited participants, 14 (1.99%) were seropositive for immunoglobulin G (IgG) antibodies against SARS-CoV-2. The cumulative prevalence of SARS-CoV-2 infection (presence of antibodies or past or current positive reverse transcription-polymerase chain reaction (RT-PCR)) was 4.40%. Conclusion The present study shows a low prevalence of SARS-CoV-2 IgG antibodies among health care workers. In addition, posting in COVID-19-positive areas was not associated with increased seropositivity. More studies are warranted to assess IgG/IgM antibodies against SARS-CoV-2 among those HCWs who are exposed to COVID-19 patients.

摘要

背景 严重急性呼吸综合征冠状病毒2(SARS-CoV-2)确诊感染病例数被严重低估。在此背景下,血清流行率调查对于评估已产生该病毒抗体、可能对后续感染具有潜在免疫力的人群比例至关重要。医护人员感染SARS-CoV-2的风险更高。因此,本回顾性研究旨在估算印度北阿坎德邦一家三级医疗机构中医护人员抗SARS-CoV-2抗体的流行率。 材料与方法 收集了2020年7月15日至8月14日期间入住该三级医疗机构新冠病毒病(COVID-19)病房并在新冠门诊就诊的704名医护人员的医院记录数据。 结果 在704名招募的参与者中,14人(1.99%)抗SARS-CoV-2免疫球蛋白G(IgG)抗体呈血清阳性。SARS-CoV-2感染的累积流行率(存在抗体或既往或当前逆转录聚合酶链反应(RT-PCR)呈阳性)为4.40%。 结论 本研究显示医护人员中SARS-CoV-2 IgG抗体流行率较低。此外,在COVID-19阳性区域工作与血清阳性率增加无关。有必要开展更多研究以评估接触COVID-19患者的医护人员中抗SARS-CoV-2的IgG/IgM抗体情况。

相似文献

1
Seroprevalence of Antibodies Against SARS-CoV-2 Among Health Care Workers at a Tertiary Care Hospital in Uttarakhand: A Retrospective Study.北阿坎德邦一家三级护理医院医护人员中抗新冠病毒 2 型抗体的血清流行率:一项回顾性研究
Cureus. 2022 May 9;14(5):e24840. doi: 10.7759/cureus.24840. eCollection 2022 May.
2
Seroprevalence of SARS-CoV-2 among high-risk healthcare workers in a MERS-CoV endemic area.MERS-CoV 流行地区高风险医护人员中 SARS-CoV-2 的血清流行率。
J Infect Public Health. 2021 Sep;14(9):1268-1273. doi: 10.1016/j.jiph.2021.08.029. Epub 2021 Aug 25.
3
Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India.印度医护人员中 SARS-CoV-2 抗体的血清阳性率及其对感染控制实践的影响。
Indian J Med Res. 2021;153(1 & 2):207-213. doi: 10.4103/ijmr.IJMR_3911_20.
4
Seroprevalence of IgG against SARS-CoV-2 and its determinants among healthcare workers of a COVID-19 dedicated hospital of India.印度一家新冠肺炎定点医院医护人员中抗新型冠状病毒2型免疫球蛋白G的血清阳性率及其决定因素
Am J Blood Res. 2021 Feb 15;11(1):44-52. eCollection 2021.
5
Prevalence of IgG antibodies against SARS-CoV-2 among healthcare workers in a tertiary pediatric hospital in Poland.波兰一家儿科三级医院医护人员中针对 SARS-CoV-2 的 IgG 抗体流行率。
PLoS One. 2021 Apr 1;16(4):e0249550. doi: 10.1371/journal.pone.0249550. eCollection 2021.
6
[SARS-CoV-2 Seroprevalence Among Healthcare Workers: Retrospective Analysis of the Data From A University Hospital in Turkey].[土耳其一家大学医院医护人员中新冠病毒血清流行率:回顾性数据分析]
Mikrobiyol Bul. 2021 Apr;55(2):223-232. doi: 10.5578/mb.20219908.
7
Enzyme-Linked Immunosorbent Assay for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) IgM/IgA and IgG Antibodies Among Healthcare Workers.用于检测医护人员中严重急性呼吸综合征冠状病毒2(SARS-CoV-2)IgM/IgA和IgG抗体的酶联免疫吸附测定
Cureus. 2020 Sep 6;12(9):e10285. doi: 10.7759/cureus.10285.
8
Seroprevalence of SARS-CoV-2 IgG antibodies among health care workers prior to vaccine administration in Europe, the USA and East Asia: A systematic review and meta-analysis.欧洲、美国和东亚医护人员在接种疫苗前SARS-CoV-2 IgG抗体的血清流行率:一项系统评价和荟萃分析。
EClinicalMedicine. 2021 Mar;33:100770. doi: 10.1016/j.eclinm.2021.100770. Epub 2021 Mar 8.
9
Higher rate of SARS-CoV-2 IgG seropositivity in hospital-based healthcare workers compared to elderly care staff in a Swedish low-prevalence region: a cross-sectional study.在瑞典低流行地区,与老年护理人员相比,医院医护人员的 SARS-CoV-2 IgG 血清阳性率更高:一项横断面研究。
Infect Dis (Lond). 2021 Nov-Dec;53(12):920-929. doi: 10.1080/23744235.2021.1959949. Epub 2021 Aug 5.
10
The prevalence of SARS-CoV-2 antibodies in triage-negative patients and staff of a fertility setting from lockdown release throughout 2020.2020年从封锁解除至全年期间,某生殖机构中分流阴性患者及工作人员体内SARS-CoV-2抗体的流行情况。
Hum Reprod Open. 2021 Jul 27;2021(3):hoab028. doi: 10.1093/hropen/hoab028. eCollection 2021.

引用本文的文献

1
Seroprevalence of anti-SARS-CoV-2 antibodies before and after implementation of anti-COVID-19 vaccination among hospital staff in Bangui, Central African Republic.中非共和国班吉医院工作人员中抗新冠病毒疫苗接种前后抗SARS-CoV-2抗体的血清流行率。
PLOS Glob Public Health. 2023 Nov 1;3(11):e0001497. doi: 10.1371/journal.pgph.0001497. eCollection 2023.
2
Durability of ChAdOx1 nCoV-19 (Covishield) Vaccine Induced Antibody Response in Health Care Workers.ChAdOx1 nCoV-19(Covishield)疫苗在医护人员中诱导的抗体反应的持久性
Vaccines (Basel). 2022 Dec 30;11(1):84. doi: 10.3390/vaccines11010084.

本文引用的文献

1
Effectiveness of video modules in infection control trainings during COVID-19 pandemic: A quasi-experimental study in tertiary care institute.视频模块在新冠疫情期间感染控制培训中的有效性:一项在三级医疗机构进行的准实验研究。
J Educ Health Promot. 2021 May 31;10(1):183. doi: 10.4103/jehp.jehp_1009_20. eCollection 2021.
2
Serosurveillance of Health Care Workers in a COVID Hospital: Immune Response, and Its Longevity.新冠医院医护人员的血清学监测:免疫反应及其持久性。
Cureus. 2021 Mar 21;13(3):e14020. doi: 10.7759/cureus.14020.
3
Seroprevalence of SARS-CoV-2 IgG antibodies among health care workers prior to vaccine administration in Europe, the USA and East Asia: A systematic review and meta-analysis.欧洲、美国和东亚医护人员在接种疫苗前SARS-CoV-2 IgG抗体的血清流行率:一项系统评价和荟萃分析。
EClinicalMedicine. 2021 Mar;33:100770. doi: 10.1016/j.eclinm.2021.100770. Epub 2021 Mar 8.
4
Seroprevalence to SARS-CoV-2 Among Healthcare Workers in an Exclusive Pediatric Hospital.一家专科医院中医护人员对新冠病毒的血清阳性率
Indian Pediatr. 2021 Mar 15;58(3):279-280. doi: 10.1007/s13312-021-2170-1.
5
Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India.印度医护人员中 SARS-CoV-2 抗体的血清阳性率及其对感染控制实践的影响。
Indian J Med Res. 2021;153(1 & 2):207-213. doi: 10.4103/ijmr.IJMR_3911_20.
6
SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey.2020 年 8 月至 9 月印度 SARS-CoV-2 抗体血清阳性率:第二次全国家庭血清学调查结果。
Lancet Glob Health. 2021 Mar;9(3):e257-e266. doi: 10.1016/S2214-109X(20)30544-1. Epub 2021 Jan 27.
7
Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study.美国大型全国范围内透析患者样本中 SARS-CoV-2 抗体的流行情况:一项横断面研究。
Lancet. 2020 Oct 24;396(10259):1335-1344. doi: 10.1016/S0140-6736(20)32009-2. Epub 2020 Sep 25.
8
Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2 IgG.用于检测抗 SARS-CoV-2 IgG 的本土 IgG ELISA 的开发。
Indian J Med Res. 2020 May;151(5):444-449. doi: 10.4103/ijmr.IJMR_2232_20.
9
A Novel Coronavirus from Patients with Pneumonia in China, 2019.2019 年中国肺炎患者中的一种新型冠状病毒。
N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.